Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03485716
Other study ID # Hypoxitrain 2
Secondary ID
Status Completed
Phase N/A
First received March 19, 2018
Last updated March 30, 2018
Start date August 1, 2016
Est. completion date December 31, 2017

Study information

Verified date March 2018
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to systematically Analyse the metabolome in capillary blood of healthy men and women at rest and during defined standardized physical activity under normobaric normoxia or hypoxia with a specific focus on metabolites and metabolic pattern related to energy metabolism. The metabolome analyses in capillary blood could give us also or more detailed insight into erythrocyte metabolic physiology because it is known for a longer time that the primary metabolism of the erythrocyte reflects its Oxygen Saturation via the glycolytic metabolites / intermediates pattern.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date December 31, 2017
Est. primary completion date March 31, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- healthy volunteers

- written informed consent

Exclusion Criteria:

- known cardio-vascular, lung, metabolic, endocrine, hematologic, kidney or neurologic diseases

- pregnancy, lactating period

- unability to understand study content and aims and to give written informed consent

Study Design


Related Conditions & MeSH terms


Intervention

Other:
running on a treadmill under normoxia or hypoxia
30 min running (60% VO2max) on a treadmill under hypoxia (O2: 14%) 30 min running (60% VO2max) on a treadmill under normoxia (O2: 20%)

Locations

Country Name City State
Germany Charite University Medicine, ECRC Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in capillary lactate/pyruvate Ratio (dimension-free) marker for the ratio between anaerobic / aerobic glycolysis t = 0 min (before exercise); t = 10, 20 and 30 min during exercise; t = 50 and 60 min during recovery
See also
  Status Clinical Trial Phase
Completed NCT01706653 - The Effects of a Polyphenol-enriched Fruit Drink on Metabolic Health N/A
Completed NCT02799498 - Compare Actions in Healthy Volunteer of 50 mg Etanercept Injection Using an Auto-injector Device and Manual Injection Phase 1
Completed NCT03202654 - Effects of Corn and Coconut Oils on Lipoprotein Lipids, Insulin Sensitivity and Inflammation N/A
Completed NCT02179931 - Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®) Phase 1
Completed NCT03995602 - The Effects of Dragon Fruit Consumption on Vascular Function. N/A
Completed NCT01643265 - Effect of Whey and Albumin Protein on Plasma Levels of Amino Acids N/A
Completed NCT04095949 - Absorption, Metabolism and Excretion of Artichoke Polyphenols in Healthy Individuals N/A
Completed NCT03553225 - Randomized, Double-blind, Controlled Study to Evaluate the Effect of Concord Grape Extract on Vascular Function in Healthy Men and Women N/A
Completed NCT04276974 - Effects of an Organic Plant-rich Diet on Gut Microbiome and Vascular Function (ORGAMIC Pilot Study) N/A
Completed NCT01836887 - The Effects of a Polyphenol-enriched Fruit Drink on Metabolic Health(2) N/A
Active, not recruiting NCT05058157 - Ketone Plasma Kinetics After Oral Intake of Different Ketogenic Formulae N/A
Completed NCT02588534 - Open-label Study Using 50 Mg Liquid Etanercept Subcutaneous Injection in the Thigh to Compare an Auto-injector Device and a Manual Injection in Healthy Subjects Phase 1